[Ocular immunopathological characteristics and the involvement of the platelet-aggregation factor and the anti-PAF at the level of the eye].
This lecture tries to systematize the data about PAF (platelet activating factor) complex implications in the different ocular immune responses, and about the therapeutical results of PAF antagonists în experimental and clinical inflammatory conditions.
Cijevschi
I
I
Clinica a II-a Oftalmologie, Universitatea de Medicină şi Farmacie Gr. T. Popa, Iaşi.
Cijevschi
D
D
D000818:Animals; D001779:Blood Coagulation Factors / Q000502:physiology*; D005123:Eye / Q000187:drug effects / Q000276:immunology* / Q000473:pathology; D005128:Eye Diseases / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D006801:Humans; D010972:Platelet Activating Factor / Q000502:physiology*; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use
D001779:Blood Coagulation Factors; D010972:Platelet Activating Factor; D010975:Platelet Aggregation Inhibitors